Abstract
Pancreaticoduodenectomy remains the only potentially curative treatment for adenocarcinoma of the pancreas. The aim of this study was to analyze prognostic factors impacting survival after R0 pancreaticoduodenectomy for adenocarcinoma in the head of the pancreas. Between 1995 and 2002, a potentially curative (R0) pancreaticoduodenectomy with pancreatogastrostomy for ductal adenocarcinoma in the head of the pancreas was performed in 81 patients (42 women and 39 men) with a mean age of 64 years (range 35–84). Patients were identified from a prospective database and records were reviewed retrospectively. Postoperative mortality was 1%, and 40% of patients had complications. Median survival was 18 months, and the 5-year survival was 24%. Fifteen patients were alive at 5 years. Factors associated with poor survival in multivariate analysis were (1) two or more positive lymph nodes, (2) tumor diameter greater than 30 mm, and (3) age greater than 70 years. In patients with no or with one positive lymph node, the 5-year survival was 44%. On the other hand, in patients with two or more positive lymph nodes, both the 3- and 5-year survival was 5%. The main risk factor associated with poor survival after an R0 pancreaticoduodenectomy for adenocarcinoma in the head of pancreas was lymph node status: The presence of two or more positive lymph nodes was associated with decreased survival.
Similar content being viewed by others
References
Schäfer M, Mullhaupt B and Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002;236:137–48.
Klinkenbijl JH, Jeekel J, Schmitz PI, Rombout PA, Nix GA, Bruining HA and van Blankenstein M. Carcinoma of the pancreas and periampullary region: palliation versus cure. Br J Surg 1993;80:1575–8.
Lillemoe KD, Cameron JL, Yeo CJ et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer ? Ann Surg 1996;223:718–25.
Reinders ME, Allema JH, van Gulik TM, Karsten TM, de Wit L.Th, & Verbeek PCM et al. Outcome of microscopicaly nonradical, subtotal pancreaticoduodenectomy (Whipple’s resection) for the treatment of pancreatic head tumours. World J Surg 1995;19:410–4.
Baumel H and Huguier M, éd. Rapport du 93e congrès de l’AFC. Le cancer du pancréas exocrine. Paris, Springer Verlag, 1991.
Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F and Rossi G. Long-term survival in pancreatic cancer: pylorus preserving versus, Whipple pancreaticoduodenectomy. Surgery 1997;122:553–66.
Trede M, Schwall G and Saeger HD. Survival after pancreaticoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–58.
Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s : pathology, complications, and outcomes. Ann Surg 1997;226:248–57.
Kuhlmann KFD, de Castro SMM, Wesseling JG et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur J Cancer 2004;40:549–58.
Yeo CJ, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 : randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg 2002;236:355–66.
Cioc AM, Ellison EC, Proca DM, Lucas JG and Frankel WL. Frozen section diagnosis of pancreatic lesions. Arch Pathol Lab Med 2002;126:1167–73.
Nakao A, Harada A, Nonami T, Kaneko T, Inoue S and Takagi H. Clinical significance of portal vein invasion by pancreatic head carcinoma. Surgery 1995;117:50–5.
Launois B, Stasik C, Bardaxoglou E, Meunier B, Campion JP, Greco L and Sutherland F. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer ? World J Surg 1999;23:926–9.
Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Boudjema K, Wolf P and Jaeck D. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile ? Am J Surg 2001;182:120–9.
Nakano H, Bachellier P, Weber JC et al. Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies. Hepatogastroenterology 2002;49:258–62.
Yeo CJ, Cameron JL, Sohn TA et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma : comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613–22.
Pedrazzoli S, Di Carlo V, Dionigi R et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508–17.
Henne-Bruns D, Vogel I, Lüttges J, Klöppel G and Kremer B. Ductal adenocarcinoma of the pancreatic head : survival after regional versus extended lymphadenectomy. Hepatogastroenterology 1998;45:855–66.
Lim JE, Chien MW and Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma. A population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74–85.
Ahmad NA, Lewis JD, Ginsberg GG et al. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol 2001;96:2609–15.
Sohn TA, Yeo CJ, Cameron JL et al. Resected adenocarcinoma of the pancreas – 616 patients : results, outcome and prognostic indicators. J Gastrointest Surg 2000;4:567–79.
Scurtu R, Bachellier P, Oussoultzoglou E, Rosso E, Maroni R and Jaeck D. Outcome after pancreaticoduodenectomy for cancer in elderly patients. J Gastrointest Surg 2006;10:813–22.
Oussoultzoglou E, Bachellier P, Bigourdan JM, Weber JC, Nakano H and Jaeck D. Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg 2004; 139:327–35.
Rosso E, Bachellier P, Oussoultzoglou E et al. Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. Am J Surg 2006;191:726–32.
Klöppel G, Solcia E, Longnecker DS et al. Histological typing of tumours of the exocrine pancreas. WHO international histology classification of tumours. Springer, Berlin, 1996.
Sobin LH and Wittekind C (eds). TNM Classification of Malignant Tumours, 6th Edition. John Wiley and Sons Ltd, 2002.
Fukuda S, Oussoultzoglou E, Bachellier P, Rosso E, Nakano H, Audet M and Jaeck D. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg 2006; in press.
Sperti C, Pasquali C, Picolli A and Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625–31.
Takai S, Satoi S, Toyokawa H et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective single-institution experience. Pancreas 2003;26:243–9.
Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JA and Bramhall SR. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 2004;21:202–9.
Laurent C, Sa Cunha A, Couderc P, Rullier E and Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 2003;90:1131–6.
McArdle CS, McMillan DC and Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005;92:1150–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zacharias, T., Jaeck, D., Oussoultzoglou, E. et al. Impact of Lymph Node Involvement on Long-term Survival after R0 Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas. J Gastrointest Surg 11, 350–356 (2007). https://doi.org/10.1007/s11605-007-0113-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-007-0113-3